bf/NASDAQ:NEXI_icon.jpeg

COM:NEXIMMUNE

NexImmune

  • Stock

Last Close

0.22

22/11 15:32

Market Cap

3.17M

Beta: -

Volume Today

1.67K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
-9.73K
-
-9.73K
0%
average payables
1.02M
-
1.97M
93.46%
1.90M
3.22%
1.71M
10.06%
669.35M
39,014.17%
average receivables
40.02K
-
3.21K
91.98%
37.23K
-
37.23K
0%
book value per share
1.11
-
0.82
25.81%
-0.80
197.09%
4.15
620.64%
1.34
67.64%
3.34
149.10%
capex per share
-0.10
-
-0.10
0.41%
-0.04
54.62%
-0.12
166.19%
-0.05
55.20%
-0.05
11.01%
capex to depreciation
-4.58
-
-2.86
37.69%
-1.40
51.07%
-2.70
93.34%
-1.26
53.28%
-0.05
96.23%
capex to operating cash flow
0.08
-
0.06
23.92%
0.03
48.97%
0.05
56.77%
0.02
52.24%
0.00
93.68%
capex to revenue
cash per share
1.23
-
0.78
36.48%
0.25
67.54%
4.05
1,492.52%
1.44
64.48%
3.05
111.93%
days of inventory on hand
days payables outstanding
days sales outstanding
debt to assets
1.69
-
0.02
-
0.01
66.36%
debt to equity
-1.21
-
0.03
-
0.02
38.21%
dividend yield
earnings yield
-0.05
-
-0.06
19.55%
-0.06
1.92%
-0.56
780.00%
87.91
15,910.15%
-13.88
115.79%
enterprise value
247.04M
-
318.29M
28.84%
514.79M
61.74%
62.73M
87.81%
-27.77M
144.27%
-803.82M
2,794.71%
enterprise value over ebitda
-18.95
-
-15.56
17.85%
-18.98
21.95%
-1.20
93.69%
0.44
137.10%
0.02
94.51%
ev to operating cash flow
-22.22
-
-16.39
26.22%
-19.50
18.93%
-1.37
92.97%
0.54
139.59%
0.03
95.29%
ev to sales
free cash flow per share
-1.23
-
-1.60
29.53%
-1.38
13.69%
-2.38
72.86%
-2.18
8.58%
-30.00
1,276.01%
free cash flow yield
-0.05
-
-0.06
29.53%
-0.05
13.69%
-0.52
849.77%
-8.97
1,633.55%
-13.51
50.68%
graham net net
0.90
-
0.54
39.48%
-1.11
304.76%
3.69
431.46%
0.99
73.07%
-1.79
280.28%
graham number
5.72
-
5.39
5.82%
5.36
0.53%
15.47
188.77%
25.41
64.24%
48.16
89.53%
income quality
0.87
-
0.94
9.07%
0.88
6.44%
0.90
1.74%
0.82
8.95%
0.97
18.65%
intangibles to total assets
0
-
0
0
0
0
0
interest coverage
-16.55
-
-58.82
255.44%
0.11
100.19%
interest debt per share
1.05
-
0.04
95.74%
-23.93
53,450.50%
0.07
100.27%
inventory turnover
invested capital
-1.21
-
0.03
-
0.02
38.21%
market cap
247.47M
-
327.42M
32.31%
500.71M
52.92%
93.06M
81.41%
5.85M
93.71%
2.33B
39,734.35%
net current asset value
9.00M
-
7.93M
11.91%
-18.66M
335.35%
79.01M
523.35%
26.61M
66.32%
316.73M
1,090.28%
net debt to ebitda
0.03
-
0.45
1,266.32%
-0.52
216.34%
0.58
211.44%
0.54
7.08%
0.10
82.33%
net income per share
-1.31
-
-1.57
19.55%
-1.60
1.92%
-2.56
60.16%
21.37
933.72%
-30.82
244.21%
operating cash flow per share
-1.14
-
-1.50
31.98%
-1.34
11.07%
-2.27
69.80%
-2.13
6.19%
-29.95
1,307.56%
payables turnover
receivables turnover
research and ddevelopement to revenue
return on tangible assets
-0.91
-
-1.48
63.07%
-2.80
89.19%
-0.57
79.70%
11.94
2,200.72%
-3.76
131.52%
revenue per share
roe
-1.19
-
-1.91
61.15%
2.01
204.98%
-0.62
130.76%
15.92
2,676.78%
-9.22
157.89%
roic
-1.26
-
-1.94
53.84%
-8.77
351.09%
-0.65
92.63%
15.11
2,437.28%
-9.21
160.99%
sales general and administrative to revenue
shareholders equity per share
1.11
-
0.82
25.81%
-0.80
197.09%
4.15
620.64%
1.34
67.64%
3.34
149.10%
stock based compensation to revenue
tangible asset value
10.81M
-
10.61M
1.84%
-15.75M
248.47%
83.76M
631.67%
32.30M
61.44%
3.51B
10,765.83%
tangible book value per share
1.11
-
0.82
25.81%
-0.80
197.09%
4.15
620.64%
1.34
67.64%
3.34
149.10%
working capital
9.33M
-
8.01M
14.14%
-18.63M
332.59%
79.06M
524.30%
27.04M
65.81%
316.73M
1,071.54%

All numbers in (except ratios and percentages)